Evaluation of mitochondria in mouse oocytes following cisplatin exposure

Qiaochu Wang1, Karla J Hutt2

  • 1Ovarian Biology Laboratory, Biomedicine Discovery Institute, Department of Anatomy and Developmental Biology, Monash University, Melbourne, Australia.

Abstract

Insights

Cisplatin chemotherapy damages immature oocytes, reducing mitochondrial membrane potential and leading to infertility. However, surviving oocytes develop normally, suggesting minimal long-term mitochondrial impact.

Area of Science:

  • Reproductive biology
  • Mitochondrial medicine
  • Chemotherapy research

Background:

  • Cisplatin, a chemotherapy drug, induces cell death by damaging DNA and mitochondria, leading to increased reactive oxygen species (ROS).
  • Immature oocytes are particularly susceptible to cisplatin, resulting in infertility and early menopause due to primordial follicle depletion.
  • The impact of cisplatin on oocyte mitochondria, beyond DNA damage, remains largely unexplored.

Purpose of the Study:

  • To investigate the short-term and long-term effects of cisplatin on mitochondria in immature oocytes.
  • To determine if cisplatin-induced mitochondrial damage contributes to oocyte loss and subsequent infertility.

Main Methods:

  • Neonatal mice were treated with saline or varying doses of cisplatin (2 mg/kg or 4 mg/kg).
  • Mitochondrial parameters including localization, mass, ATP content, and membrane potential (TMRM staining) were assessed in immature oocytes at 6 and 24 hours post-treatment.
  • Oocyte quality and mitochondrial function were evaluated in mature oocytes 5 weeks after cisplatin exposure.

Main Results:

  • Short-term cisplatin exposure (6-24h) decreased mitochondrial membrane potential in immature oocytes, indicating apoptosis induction.
  • Five weeks post-treatment, cisplatin-exposed mice yielded significantly fewer mature oocytes compared to controls.
  • No significant differences in mitochondrial localization, mass, membrane potential, or ATP levels were observed in mature oocytes from cisplatin-treated mice.

Conclusions:

  • Mitochondrial dysfunction likely contributes to cisplatin-induced depletion of the ovarian reserve.
  • While short-term mitochondrial damage occurs, surviving oocytes develop into mature oocytes with normal mitochondrial function, suggesting limited long-term effects.